Epstein-Barr virus (EBV) is a herpes virus that is associated with several human cancers. Infection of B cells by EBV leads to their induction and maintenance of proliferation and requires the oncogene, latent membrane protein 1 (LMP1). LMP1 signals in a ligand-independent manner and is expressed at widely different levels in cells of a single clone. It is this unusual distribution that allows LMP1 to stimulate multiple, distinct pathways. Average levels of LMP1 induce proliferation while high levels induce cytostasis and inhibition of protein synthesis. These inhibitory pathways are induced by the six transmembrane domains of LMP1. We uncovered a novel function encoded by transmembrane domains 3-6 of LMP1; they induce autophagy in a dose-dependent manner and thus, modify the physiology of their host. Cells that express low levels of LMP1 display early stages of autophagy, autophagosomes; those that express high levels of this oncogene display late stages of autophagy, autolysosomes. Inhibition of autophagy in EBV-positive cells leads to an accumulation of LMP1 and a decreased ability to form colonies. These results indicate that LMP1's induction of autophagy contributes to its own regulation and that of its host cell.
Introduction
Autophagy can mediate both cell survival and cell death depending on the cell type, stimuli and the molecular components involved (Baehrecke, 2005 ). It appears to be required for the survival of neurons in vivo and of neuroblastoma cells in vitro (Komatsu et al., 2006) . In yeast, autophagy has been associated with the cell's response to nutrient deprivation. This cellular process is not obviously involved in control of cellular proliferation. We have found, however, that the latent membrane protein (LMP1) oncogene of Epstein-Barr virus (EBV) induces autophagy dose dependently in infected B cells.
Autophagy is a cellular process that leads to the degradation of proteins and organelles in the cytoplasm (Yoshimori, 2004) . It causes dramatic physiological changes in cells in which new organelles, autophagosomes, form as double-membrane structures that engulf cytosolic components, and close. Autophagosomes fuse with lysosomes to form autolysosomes, which degrade their engulfed components. Formation of the doublemembrane structures is mediated by the class III phosphatidyl-inositol (PI3)-kinase complexes. Beclin-1, a member of the class III PI3K complex, mediates the localization of other autophagy-related proteins to the preautophagosomal membrane for its elongation (Tassa et al., 2003) . Two evolutionarily conserved proteins, LC3I and ATG12, which are recruited to the preautophagosomal membrane, undergo ubiquitylation-like modifications. LC3I becomes modified to LC3II, which is then inserted into autophagosomal membranes and thus, has been identified as an autophagosomal marker in mammalian cells (Kabeya et al., 2000; Tanida et al., 2004) . ATG12 is conjugated to ATG5 to form autophagosomal precursors (Mizushima et al., 1998) . Both LC3I and ATG12 are activated by another conserved protein, an E1-like enzyme, ATG7.
LMP1 is an oncogene whose signaling is required for the proliferation of infected B cells (Kaye et al., 1993; Kilger et al., 1998; Dirmeier et al., 2003) . It has six membrane-spanning domains and a long cytoplasmic C-terminal signaling domain which binds cellular proteins such as TRAFs, JAK3 and TRADD to mediate signaling via nuclear factor (NF)-kB, AP-1 and Stat-1 (Mosialos et al., 1995; Devergne et al., 1996; Kieser et al., 1997; Sandberg et al., 1997; Gires et al., 1999) . This signaling partially mimics that of the cellular CD40 receptor which also regulates proliferation of B cells dependent on its binding to CD40 ligand (Uchida et al., 1999; Lam and Sugden, 2003) . LMP1 differs, however, from CD40 in at least two fundamental properties. First, LMP1 signals in the absence of a ligand but dependent on its six membrane-spanning domains. This moiety regulates LMP1's trafficking, aggregation and dose-dependent induction of the unfolded protein response (UPR) Kaykas et al., 2002; Lee and Sugden, 2007, submitted) . Second, LMP1 is expressed at levels varying over 100-fold in individual cells of clonal populations (Lam et al., 2004) . This variation is controlled in part autocatalytically and requires LMP1's induction of the UPR (Lee and Sugden, 2007, submitted) .
We have examined B cells engineered to express LMP1 conditionally and populations of EBV-infected cells that express LMP1 at different levels. These cells display different stages of autophagy dependent on their levels of expression of LMP1. Naive B cells or uninfected B-cell blasts do not show detectable features of autophagy. B cells showing the most advanced stages of autophagy support rapid degradation of LMP1, survive and regenerate populations of cells with all stages of autophagy. Finally, inhibiting autophagy in EBV-transformed B cells leads to the accumulation of unphysiological levels of LMP1. Thus, LMP1 regulates autophagy in EBV-infected B cells with one consequence of this regulation being a limitation of its own accumulation.
Results

Exogenous expression of LMP1 in EBV-negative B cells induces autophagy
To ask whether LMP1 induces autophagy, we examined LMP1's ability to induce the conversion of LC3I to LC3II. BJAB/HALMP1 cells (Lam et al., 2004) were treated with tetracycline to induce the expression of LMP1. Expression of LMP1 elicited the processing of endogenous LC3, which is a distinctive feature of induction of autophagy ( Figure 1a) . A greater than five-fold increase of LC3II levels was observed in cells treated with tetracycline compared to untreated cells (Po0.05). An electron microscopic analysis confirmed the induction of autophagy in BJAB/HALMP1 cells. Expression of LMP1 in these cells induced the formation of autophagosomes and autolysosomes ( Figure 1c ). Autophagosomes were identified as double-membrane structures containing cytoplasmic content. Autolysosomes were characterized as single-membrane structures with high-density materials and signs of degradation of their content. These findings show that the exogenous expression of LMP1 in B cells can induce autophagy.
The transmembrane domains 3-6 of LMP1 are sufficient to induce autophagy LMP1 is an integral membrane protein that has six membrane-spanning domains and a long C-terminal signaling domain (Bornkamm and Hammerschmidt, 2001) . To determine if the expression of the six transmembrane domains of LMP1 alone can induce autophagy, BJAB/HA6MLMP1-green fluorescent protein (GFP) cells were used. This cell line has been engineered to express a derivative of LMP1 that expresses only the N terminus and six transmembrane domains of LMP1 conditionally upon treatment with tetracycline (Lam et al., 2004) . Western blot analysis showed that the level of LC3II was increased in cells expressing the six transmembrane domains of LMP1 (Figure 1b) . A greater than five-fold increase of LC3II levels was observed in these cells, which is comparable to the one observed with full-length wild-type LMP1 (Po0.05). These data show that the six transmembrane domains of LMP1 are sufficient to induce autophagy. Figures 1a and b also show that the steady-state levels of LC3I increase with LMP1 expression. The increase of LC3I level does not occur through any of the known transcriptional mediators regulated by LMP1 such as NF-kB, STAT or JAK3 because it occurs even in the absence of the C-terminus of LMP1. Any signaling event responsible for this increase would originate from the six transmembrane domains.
To determine which transmembrane domain of LMP1 is required to induce autophagy, BJAB cells were electroporated with derivatives that express different transmembrane domains fused to GFP: 1-2TM LMP1-GFP, 3-6TM LMP1-GFP and 1-6TM LMP1-GFP. As in Figure 1b , 1-6TM LMP1-GFP induced the processing of endogenous LC3 (Figure 1d) . A three-fold increase of LC3II levels was observed in these cells (Po0.05). Expression of 3-6TM LMP1-GFP was sufficient to induce a comparable fold increase of LC3II levels to the one observed with 1-6TM LMP1-GFP (Po0.05) (Figure 1d ). However, 1-2TM LMP1-GFP did not induce any LC3 processing above background. The transmembrane domains 3-6 of LMP1 are sufficient to induce autophagy.
LMP1 induces autophagy in EBV-infected cells
If the induction of autophagy were to be a consequence of infection of normal B cells by EBV, then EBVpositive lymphoblastoid cell lines (LCL) should display some features of autophagy. Cells of the LCL, 721, that expressed high levels of LMP1 had a 2.5-fold higher level of LC3II compared to cells with low levels of LMP1 (Po0.05) (Figure 2a ). This result confirms that untreated, normal, EBV-positive cells support autophagy dependent on their levels of expression of LMP1. We also used electron microscopic analysis to score for the activation of autophagy in EBV-positive cells. To isolate live cells that express low or high levels of LMP1 we used an EBV-positive strain derived by infecting primary B cells isolated from blood with a recombinant EBV that expresses LMP1-mRFP. EBV-positive cells expressing high levels of LMP1 were separated by fluorescence-activated cell sorting (FACS) and had a 2.5-fold higher level of LC3II compared to sorted cells with low levels of LMP1 (Po0.05) (Figure 2b ). These EBV-positive cells were then analysed by electron microscopy (EM). We observed autophagosomes in 40% of the cells with low levels of LMP1. Greater than 80% of cells with high levels of LMP1 had some autophagosomes but most showed evidence of the structures characteristic of the late stages of autophagy, autolysosomes (Figure 2c ). In summary, these results in combination indicate that whether expressed exogenously or in the context of EBV, LMP1 induces autophagy and that increasing levels of LMP1 induce later stages of autophagy in B cells.
From the EM micrographs, it became clear that cells that express low levels of LMP1 mostly had autophago-somes and cells that express high levels of LMP1 mostly had autolysosomes (Figure 2c ). To confirm this observation, 721 or cells of EBV-positive strains that express wild-type LMP1 were stained with Lysotracker Red (LT red), which stains lysosomal membranes. When BJAB/HALMP1 cells treated with tetracycline to induce LMP1's expression and the late stages of autophagy were stained with LT red, they showed higher levels of Figure 1 Exogenous expression of transmembrane domains 3-6 of latent membrane protein 1 (LMP1) in EBV-negative B cell is sufficient to induce autophagy. BJAB/HALMP1 (a) or BJAB/HA6MLMP1-green fluorescent protein (GFP) (b) cells were left untreated or treated with 10 ng of tetracycline per ml for 48 h to induce LMP1. The cells were harvested and analysed by western blotting using anti-LC3, anti-LMP1 and anti-tubulin antibodies. A representative example of three independent experiments is shown. (c) Electron microscopic analysis of BJAB/HALMP1 cells either untreated or treated with 10 ng of tetracycline per ml. Lower panels are higher magnification images of the upper panels. The nucleus (N), autophagosomes (arrow) and autolysosomes (arrow head) are indicated. The number of cells analysed in each condition is shown in the table below the panels. (d) BJAB cells were electroporated with vector alone, 1-2TM LMP1-GFP, 3-6TM LMP1-GFP and 1-6TM LMP1-GFP. GFP-positive cells were sorted, harvested and then analysed by western blotting using anti-LC3, anti-GFP and anti-tubulin antibodies. BJAB/HA6MLMP1-GFP cells untreated or treated with 10 ng of tetracycline per ml were utilized as negative and positive controls, respectively. A representative example of three independent experiments is shown.
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LT red intensity than untreated cells (unpublished observation). This finding indicates that cells which have autolysosomes stain intensely with LT red because they have both lysosomal and autolysosomal membranes that bind the stain. We hypothesized that if cells that have high levels of LMP1 preferentially have autolysosomes, then cells sorted for the highest intensity of LT red will have high levels of LMP1 and conversely cells with low intensities of LT red will have low levels of LMP1. This hypothesized distribution was observed in strains of EBV-positive cells that express wild-type LMP1 ( Figure 3a ) and in 721 cells (Figure 3b ) when they were analysed after being sorted based on the intensity of staining by LT red. A seven-fold and 12-fold increase of LMP1 levels was observed in cells sorted for high LT red compared to cells sorted for low LT red in EBV-positive strains and 721 cells, respectively (Po0.05) (Figure 3) . These results are consistent with the idea that EBV-positive cells with low levels of LMP1 induce the early stage of autophagy while cells with high levels of LMP1 induce the later stages of autophagy. (Figure 4b ). These results, combined with those from EBV-negative cells, indicate that EBV induces autophagy in infected B cells and that LMP1 is necessary for this induction. Six transmembrane domains of LMP1 induce autophagy DY Lee and B Sugden 2000) . Cells that express high levels of LMP1 recover to generate a population that mirrors the parental one (Lee and Sugden, 2007, submitted) . These cells must evolve to yield lower levels of LMP1 to proliferate and regenerate a population with different stages of autophagy. To determine if cells expressing high levels of LMP1 decrease their levels of LMP1 over time, 721 cells were sorted for those that stain intensely with LT red and thus express high levels of LMP1. The total levels of LMP1 decreased rapidly with time in these sorted cells (Figure 5a ). This observation was extended to an EBVpositive strain of cells (data not shown). These two observations are startling for their magnitude. LMP1 turns over in 3-8 h as measured in pulse chase experiments (Baichwal and Sugden, 1987; Martin and Sugden, 1991) . Our findings indicate that the entire pool of LMP1 in these cells that both express it at high levels and support the late stages of autophagy turns over with The cells were then harvested every 24 h for 72 h. All samples were analysed by western blotting using anti-tubulin and anti-LMP1 antibodies at the same time. 721 cells were infected with a control retrovirus or a retrovirus that encodes an shRNA to Beclin-1. Cells were either harvested and analysed by western blotting using anti-Beclin-1 and anti-tubulin antibodies (b) or fixed and stained for LMP1 (d). Cells stained for LMP1 were analysed on FACS-Vantage (Becton Dickinson). Data were analysed with FlowJo software. The mean for 721 is 15 225 and for Beclin-1 is 67 240. 721 cells were infected with a control retrovirus or a retrovirus that encodes an shRNA to ATG7. Cells were either harvested and analysed by RT-PCR (c) or fixed and stained for LMP1 (e). These cells were analysed as described in (d). The mean for 721 is 8542 and for ATG7 is 16 531. (f) Four different clones of 721 cells infected with retrovirus that encodes an shRNA to ATG7 or Beclin-1 were harvested and analysed by western blotting using anti-LMP1 and anti-tubulin antibodies. (g) Infected cells were plated into multiple wells of 96-well plates containing human fibroblast feeder layers. Wells containing surviving and proliferating cells were identified visually at 14 days after sorting. The cloning efficiency was determined using the Poisson distribution. Averages of three independent experiments are shown. *Po0.05. this rate. This turnover, thus, is likely occurring in the absence of new synthesis of LMP1. These data show that the total level of LMP1 decreases rapidly in cells that initially express high levels of LMP1.
To determine if there is a link between autophagy and LMP1's levels of expression, 721 cells were infected with a retrovirus that encodes an shRNA to Beclin-1 or ATG7 embedded in a miRNA gene. Both Beclin-1 and ATG7 are genes essential for the induction of autophagy (Ichimura et al., 2000; Tassa et al., 2003) . Reduction of Beclin-1 protein levels was confirmed by western blot analysis and reduction of ATG7 mRNA levels was confirmed by reverse transcription (RT)-PCR (Figures  5b and c) . Inhibition of autophagy led to an increase in the levels of LMP1 (Figures 5d, e and f) . If the levels of LMP1 accumulate in the absence of autophagy and cells cannot decrease their levels of LMP1, cells that express high levels of LMP1 would not be able to recover from their cytostasis. We hypothesized that in the absence of autophagy, cells will have a decreased ability to form colonies due to their inability to regulate the levels of expression of LMP1. To test this hypothesis cells infected with retroviruses that encode an shRNA to Beclin-1 or ATG7 were directly deposited into multiple wells of 96-well plates containing human fibroblast feeder layers. Wells containing surviving and proliferating cells were identified visually and the cloning efficiency was determined using the Poisson distribution. Inhibiting Beclin-1 inhibited the cloning efficiency of these EBV-positive cells by 50%; inhibiting ATG7 inhibited their cloning efficiency by 30% (Po0.05) (Figure 5g ). This seemingly modest difference observed in the cloning efficiency reflects the fact that most cells will have low and intermediate levels of LMP1 when infected with the retroviral vectors such that the cells will generate progeny before any one cell accumulates sufficient LMP1 to induce a mature state of autophagy. Only those cells that have high levels of LMP1 will induce cytostasis and remain in a cytostatic state due to their inability to decrease the levels of LMP1 in the absence of autophagy. These data show that inhibiting autophagy leads to an accumulation of levels of LMP1 in EBV-positive cells and inhibits their colony formation.
Discussion
We have found that the LMP1 oncogene that regulates proliferation of EBV-infected B cells also activates autophagy in a dose-dependent manner in these cells. We showed that normal B cells or activated blasts do not have any detectable levels of autophagy. The LMP1 oncogene is required for the induction of autophagy in EBV-infected cells as shown in the contrast between MutuI and MutuIII (Figure 4b) . We have examined the mechanism involved in LMP1's induction of autophagy. Only transmembrane spanning domains 3-6 are required for this induction indicating that LMP1's cytoplasmic C-terminal domain, which can activate the NF-kB, AP-1 and Stat-1 signaling pathways, and transmembrane spanning domains 1 and 2, which are necessary for aggregation, are not involved in the induction of autophagy (Figure 1d ). This is an exciting finding because no explicit role has been previously identified for transmembrane spanning domains 3-6.
We have also demonstrated that cells that have high levels of LMP1 and induce autophagy support efficient degradation of LMP1 (Figure 5a ). We found that inhibiting two mediators of autophagy, Beclin-1 and ATG7, leads to the unphysiological accumulation of LMP1 in EBV-infected cells and inhibits their growth and/or survival (Figure 5f ). Autophagy is thus required for regulating the level of LMP1 either indirectly or directly. The mechanism to downregulate LMP1 may be a substitute for withdrawal of ligand for liganddependent receptors such as CD40. It has been shown previously that aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy (Ravikumar et al., 2002 ). LMP1's induction of autophagy may facilitate the clearance of its own aggregates and allow cells to escape from direct immune recognition by CD4 þ T cells. While the processing of one EBV protein, EBNA1, apparently requires autophagy for delivery to MHC class II molecules, that for the more commonly recognized antigens, EBNA2 and EBNA3C does not (Paludan et al., 2005; Taylor et al., 2006) .
The most surprising conclusion from our findings comes from our observations of EBV's cyclical regulation of autophagy through LMP1. EBV induces and maintains proliferation of infected B cells so that clonal populations of cells proliferate exponentially. The levels of LMP1 and stage of autophagy determine the rate at which a cell within an EBV-positive population will proceed through the cell cycle. Those with intermediate levels of LMP1 will transit it most efficiently and thus constitute the majority of the population. Those with high levels of LMP1 are inhibited in their general protein synthesis and can be arrested throughout the cell cycle until the levels of LMP1 decrease (Lam et al., 2004) . EBV has evolved a mechanism that drives cells with extremes in levels of LMP1 to evolve to express it at intermediate levels and to proliferate to allow the population's continued exponential growth. This mechanism likely provides EBV a selective advantage in vivo. Cells with extremes in levels of LMP1 may evade immune responses either because at low levels they express too little antigen or at high levels they are resistant to cytokine-induced apoptosis (Kaykas and Sugden, 2000) ; those cells that evade these responses will readily regenerate the parental, proliferating population.
Materials and methods
Cell culture
The cell lines BJAB/HA-LMP1 and BJAB/HA6MLMP1-GFP have previously been described (Lam et al., 2004) . 721 is an EBV-positive LCL (Kavathas et al., 1980) . MutuI and MutuIII are EBV-positive Burkitt's lymphoma cell lines (Gregory et al., 1990) . EBV-positive strain cells, 721, MutuI and MutuIII were grown in RPMI 1640 medium (GibcoBRL, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum. BJAB/HA-LMP1 and BJAB/HA6MLMP1-GFP were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum, 1 mg G418 ml À1 and 1 mg puromycin ml
À1
. All cell culture media were supplemented with 200 U of penicillin ml À1 and 200 mg of streptomycin ml
, and cells were grown at 37 1C in a 5% CO 2 humidified atmosphere.
Recombinant EBV
Generation of recombinant EBV has previously been described (Dirmeier et al., 2005) . The plasmid p2167.1 (Dirmeier et al., 2003) was modified to express a fusion protein of LMP1-mRFP. The stop codon of LMP1 was replaced with a linker GGCCAGAGTGGTCCCGGTGGT followed by the open reading frame of mRFP. The resulting maxi-EBV plasmid was checked by restriction analyses (data not shown) and then used to establish virus-producing 293 cell lines (Delecluse et al., 1998; Neuhierl et al., 2002; Dirmeier et al., 2003; Humme et al., 2003) . Primary B cells were isolated from human blood according to the protocol provided in the Miltenyi Biotech Human B cell Isolation Kit II (MACS). Primary human B lymphocytes purified from blood were infected with the recombinant EBV virus with a multiplicity of infection of 1 to produce an EBV-positive strain that expresses LMP1-mRFP.
Western blotting
Cells were solubilized with 1 Â SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer made from a dilution of a 2 Â stock solution with 1 Â radioimmuno precipitation assay buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.5% SDS). Samples were briefly sonicated. Cell lysates (1 Â 10 5 cells per sample) were separated by SDS-10% PAGE for LMP1, Beclin-1, tubulin, SDS-12% PAGE for GFP and SDS-15% PAGE for LC3 and transferred to nitrocellulose membranes. The blots were blocked with 5% nonfat milk and probed with primary antibodies followed by alkaline phosphatase-labeled secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA). A combination of 5-bromo-4-chloro-3 0 -indolyphosphate p-toluidine salt and nitronlue tetrazolium chloride was utilized as detection method to yield an intense, insoluble black-purple precipitate. The western blots were scanned and signals were quantified using ImageQuant software. The following primary antibodies were used: mouse monoclonal anti-LMP1 antibody CS1-4 (Dako, Carpinteria, CA, USA) at 1:500, rabbit polyclonal anti-GFP antibody (Clontech, San Jose, CA, USA) at 1:400, mouse monoclonal anti-a tubulin antibody (Sigma-Aldrich, St Louis, MO, USA) at 1:2000, mouse monoclonal anti-Beclin-1 antibody (BD Biosciences, San Jose, CA, USA) at 1:500 and anti-LC3 at 1:500 (kindly provided by Dr Takashi Ueno).
Lysotracker red staining A total of 10 6 cells were resuspended in 1 ml of RPMI 1640 medium (GibcoBRL) supplemented with 10% fetal bovine serum. They were incubated for 5 min at 37 1C. These cells were stained with 75 nM Lysotracker red DND-99 (Molecular Probes, Carlsbad, CA, USA) final concentration and incubated at 37 1C for 30 min to 1 h. Single cells were sorted on FACS-Vantage SE with FACS-DIVA option (Becton Dickinson, San Jose, CA, USA).
RNA interference
To construct human Beclin-1 shRNA vector, an oligonucleotide with the sequence TgCTgTTgACAgTgAgCgAACAg TTTggCACAATCAATAATAgTgAAgCCACAgATgTATTA TTgATTgTgCCAAACTgTCTgCCTACTgCCTCggA was purchased from IDT. To construct human ATG7 shRNA vector, an oligonucleotide with the sequence TgCTgTTgA CAgTgAgCgCAggAgTCACAgCTCTTCCTTATAgTgAAg CCACAgATgTATAAggAAgAgCTgTgACTCCTTTgCCTA CTgCCTCggA was purchased from IDT. These inserts were cloned in the MSCV-TMP vector according to manufacture's protocol (Open Biosystems, Huntsville, AL, USA). The fragment that contains mirRNA30 and the desired shRNA was removed from the MSCV-TMP vector using HpaI and AgeI. This fragment was cloned in the pCMMP-MCS-ireseGFP, p3051.
Retroviral production and infection
Retrovirus was generated by cotransfecting 293T in a 70% confluent 10 cm dish with 3 mg of a plasmid encoding the GagPol element, 1 mg of a plasmid encoding the vesicular stomatitis virus G protein, 1 mg of a plasmid encoding the p50/p65 subunits of NF-kB and 10 mg of a plasmid carrying the retroviral backbone encoding shRNA to ATG7 or Beclin-1 using polyethylenimine, PEI (Sigma-Aldrich). About 40 mg of PEI per 10 cm dish was used. The culture medium was replaced with Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 24 h posttransfection. On days 3 and 4 posttransfection, the media was collected and filtered through a 0.8 mm pore-size filter. The retrovirus was concentrated via sedimentation at 36 000 r.p.m. for 2.5 h in oakridge tubes in a Ti 50 Rotor, resuspended in RPMI 1640 medium supplemented with 10% fetal bovine serum and 50 mM HEPES, and stored in À80 1C. The titers of the viral stocks were measured by infecting BJAB cells plated at 5 Â 10 4 cells per well of a 24-well plate with 1:5 serial dilutions of viral stocks. Infected cells were identified by the expression of eGFP, and titers were calculated according to the Poisson distribution. 721 cells growing exponentially were infected with 10 green BJAB units by incubating the suspension in complete medium with 50 mM HEPES for 1 h at 4 1C with gentle rocking. After the incubation, cells were resuspended in 10 ml of complete medium, and incubated at 37 1C. After 48 h of infection, single cells were sorted on a FACS-Vantage SE with FACS-DIVA option (Becton Dickinson).
RT-PCR
RNA was prepared using an RNeasy Mini Kit from Qiagen. Each reaction contained 100 ng RNA, 1 Â EZ buffer (GeneAmp, Applied Biosystems, Foster City, CA, USA), 0.4 M Betaine (Sigma-Aldrich), 75 ng primers, 300 mM dNTPs, 2.5 Mn(OAc) 2 and 5 units of rTth polymerase (GeneAmp, Applied Biosystems). The forward primer, ATgCCTgggCATCCAgT gAACTTC, and the reverse primer, CATCATTgCAgAAg TAgCAgCCA, were used for ATG7. The forward primer, gAgCCAAAAgggTCATC, and the reverse primer, gTggTCAT gAgTCCTTC, were used for glyceraldehyde-3-phosphate dehydrogenase. The conditions for the reaction are as follows: 60 1C for 30 min, 95 1C for 5 min, 25 cycles of 95 1C for 1 min, 52 1C for 2 min, 60 1C for 1 min and 10 min at 60 1C.
Cloning efficiency
Infected cells were directly deposited into multiple wells of 96-well plates containing human fibroblast feeder layers. Wells containing surviving and proliferating cells were identified visually at 14 days after sorting. The cloning efficiency was determined using the Poisson distribution. Cloning efficiency ¼ (Àln (number of negative wells))/number of cells plated per well.
Electron microscopy
Samples were fixed for 2 h in 2.5% glutaraldehyde, 2.0% paraformaldehyde buffered in 0.1 M sodium phosphate buffer (PB) at 4 1C and post-fixed in 4% osmium tetroxide, 1% potassium ferrocyanide in 0.1 M PB for 1 h at room temperature (RT). The samples were dehydrated in a graded series of ethanol at the increasing percentages 35, 50, 70, 80 and 90% for 5 min, 95% for 10 min and 100% 3 Â 10 min at RT. Fully dehydrated samples were infiltrated in increasing concentrations of PolyBed 812 (Polysciences Inc., Warrington, PA, USA) and PO mixtures. The samples were embedded in fresh PolyBed 812 for 48 h at 60 1C and then sectioned on a Leica EM UC6 ultramicrotome at 80 nm. The sections were collected on Pioloform (Ted Pella Inc., Redding, CA, USA) coated 2 Â 1 oval-slot grids and bare 300 mesh Cu thin-bar grids (EMS, Hatfield, PA, USA), and poststained in uranyl acetate and lead citrate. The sectioned samples were viewed at 80 kV on a JEOL100CX microscope, equipped with MegaView III camera (Olympus Soft Imaging System, Lakewood, CO, USA).
Electroporation BJAB cells were transfected by electroporation. A total of 5 Â 10 6 cells were electroporated in 500 ml of RPMI 1640 medium supplemented with 10% fetal bovine serum and 50 mM HEPES with a custom-built electroporator at 1500 V, three capacitor banks with 1540 mF of capacitance, R-adjust set at 0600 and a rise time set at 1000 as described previously (Knutson and Yee, 1987) .
Staining and FACS analysis
For the staining of LMP1, the cells were fixed with a 1:1 mixture of acetone-methanol and then permeabilized with 0.1%. Triton X-100. The fixed cells were washed two times with 1 Â phosphate-buffered saline (PBS) and blocked in 1 Â PBS plus 5% bovine serum albumin (BSA; SigmaAldrich); stained with mouse monoclonal anti-LMP1 antibody CS1-4 (Dako) at 1:500; washed three times with 1 Â PBS plus 5% BSA and finally stained with an appropriate secondary antibody labeled with AlexaFluor 647 (Molecular Probes). The stained cells were analysed on FACS-Vantage SE with FACS-DIVA option (Becton Dickinson). Data were analysed with FlowJo software. 
Statistical analysis
